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b-Aminopropionitrile-induced aortic aneurysm and
dissection in mice
Hisashi Sawada, MD, PhD,a,b,c Zachary A. Beckner, BS Candidate,a,b Sohei Ito, MD, PhD,a,b
Alan Daugherty, PhD, DSc,a,b,c and Hong S. Lu, MD, PhD,a,b,c Lexington, Ky

ABSTRACT
The mechanistic basis for the formation of aortic aneurysms and dissection needs to be elucidated to facilitate the
development of effective medications. b-Aminopropionitrile administration in mice has been used frequently to study
the pathologic features and mechanisms of aortic aneurysm and dissection. This mouse model mimics several facets of
the pathology of human aortic aneurysms and dissection, although many variables exist in the experimental design and
protocols that must be resolved to determine its application to the human disease. In the present brief review, we have
introduced the development of this mouse model and provided insights into understanding its pathologic
features. (JVSeVascular Science 2022;3:64-72.)
Keywords: b-Aminopropionitrile; Aortic aneurysms; Aortic dissection; Mouse

Aortic aneurysm and dissection (AAD) are devastating
diseases. Aortic aneurysms are deﬁned as pathologic
luminal dilatations with a high risk of uncontrolled
bleeding due to aortic rupture and death.1-3 Aortic aneurysms are most common in the infrarenal abdominal
aortic region,4 with the proximal thoracic aortic region
as the second most common location.5,6 Aortic dissection
leads to bleeding into the medial layers in the thoracic
aorta and can extend into the abdominal aorta, causing
organ malperfusion with critical consequences.1-3 Surgical procedures have been the primary therapy because
no medications have been proved effective. Therefore,
research using animal models that mimic facets of the
human disease will hopefully provide mechanistic insights that will lead to a path for the development of
effective medical therapies.
Although many animal models of AAD have been
developed, an increasingly common model is based on
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the administration of b-aminopropionitrile (BAPN) in
mice. One premise for developing this model was the
observation that turkeys died of aortic rupture after
eating sweet peas, with the subsequent identiﬁcation
of BAPN as the active constituent.7,8 The mechanistic basis for BAPN-induced aortopathy was proposed to be the
inhibition of lysyl oxidase (LOX) activity, which catalyzed
crosslinking of lysine residue in elastin and collagens to
form desmosine. These extracellular matrix proteins are
crucial components for maintaining aortic integrity.9-11
Several studies have demonstrated that chronic BAPN
administration results in AAD formation in mice,
providing a model to investigate the pathophysiology
and mechanisms of AAD.12-14 BAPN administration has
been used frequently with angiotensin II (AngII) infusion
to promote AAD formation in mice. However, BAPN
administration alone can also induce heterogeneous
aortic pathologies that mimic facets of the human disease. In the present review, we have highlighted studies
that used BAPN as the only chemical intervention to
induce AAD in mice, summarized the BAPN-induced
AAD pathologies and their detection using imaging modalities, and provided suggestions for optimal experimental designs.
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DEVELOPMENT OF BAPN-INDUCED AAD IN MICE
Effects of BAPN on LOX and LOX-like proteins. LOX
and LOX-like protein (LOXL) family members, LOXL1 to
LOXL4, are essential enzymes for the crosslinking of
elastin and collagens.15 LOX-deﬁcient mice exhibit disrupted elastin and collagen crosslinking.16 However, no
studies have investigated AAD in mice deﬁcient in any of
the LOXL proteins. A missense mutation in LOX has been
identiﬁed in patients with AAD that was replicated in a
mouse model with this LOX mutation.17 These ﬁndings
support the notion that disruption of LOX contributes to
the formation of AAD.
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BAPN was reported initially as an irreversible pharmacologic inhibitor of LOX and LOXL proteins.18-20 BAPN
decreased LOX activity, as demonstrated using puriﬁed
LOX from bovine aortas or chick cartilages.18,19 An
in vitro study using Escherichia coli showed that LOXL1
and LOXL2 were also inhibited by BAPN.20 However, a
recent report demonstrated that BAPN inhibited LOXL2
effectively in vitro but not LOX.21 No studies have reported the contribution of LOXL2 to AAD using in vivo
models. Further study is needed to provide a consensus
of which enzymes in the LOX/LOXL family are inhibited
by BAPN. In addition, more insight is required regarding
the roles of LOXL enzymes in AAD pathophysiology.
BAPN administration. Many of the initial studies had
induced aortopathies by a combination of BAPN administration with another mode of provoking AAD. This was
initially demonstrated by coadministration of BAPN
and AngII, which induced AAD in adult male C57BL/6J
mice.22,23 Adult mice had not shown overt aortic pathologies when BAPN was administered alone.22 Subsequent studies have demonstrated that BAPN
administration combined with other manipulations will
induce AAD in adult mice, including application of
elastase to the adventitia of the infrarenal aorta or
administration of DOCA (deoxycorticosterone acetate)salt.22,24,25 Among these manipulations, AngII infusion
has been used most often in conjunction with BAPN to
enhance AAD formation. In young (3-week-old) mice,
AAD formation was observed with a 100% incidence
when BAPN was administered for 4 weeks with an AngII
(1 mg/kg/min) infusion for 24 hours before termination.12
In 3- to 4-week-old mice after 3 to 4 weeks of BAPN
administration, AngII infusion for 12, 24, and 48 hours led
to death due to rupture at an incidence of 14% (7 of 50),
39% (18 of 46), and 67% (29 of 43), respectively.26 Therefore, studies have demonstrated consistently that transient AngII infusion augments BAPN-induced AAD.
Accumulating evidence has shown that BAPN administration alone will induce AAD formation in young mice.
In one study, 3-week-old male C57BL/6 mice had >80%
AAD formation during BAPN administration without
other manipulations.12 BAPN administration started at 3
to 4 weeks of age suppressed elastogenesis but did not
induce elastolysis.27 BAPN irreversibly inhibits crosslinking of elastin and collagen. However, crosslinking of
elastin and collagen is presumed to be minimal after
the postnatal phase. Thus, inhibition of LOX/LOXL activity
might not disrupt already formed elastic ﬁbers. Patients
with connective tissue disease, such as Marfan syndrome,
Ehlers-Danlos syndrome, or Turner syndrome, often
develop the complication of aortic dissection. The incidence of aortic complications peaks at 30 to 40 years
of age in patients with these syndromes.28-30 Because
BAPN administration in young mice (age, 3-4 weeks)
leads to AAD formation through the inhibition of elastin

and collagen crosslinking during extracellular matrix
maturation, this mouse model might mimic certain molecular mechanisms of aortic diseases complicated by
the connective tissue diseases mentioned above.
Route and dose of BAPN administration. BAPN has
been administered in several modes in mouse studies.
Mini-osmotic pumps can be used to deliver BAPN to
adult mice (age, 7-15 weeks).22,31-36 However, it has been
more common to administer BAPN in the drinking water
for young mice (age, 3-4 weeks). A few studies have used
BAPN administration via a gastric tube,26 diet,12,37 or
intraperitoneal injection.38
Mini-osmotic pumps provide a constant and continuous
delivery of compounds. This approach has been used
extensively for delivery of AngII to induce aortic aneurysms
in mice.39,40 Given a previous study demonstrating that
the half-life (beta phase) of BAPN was 79 6 5 minutes in
rabbits,41 subcutaneous infusion using osmotic pumps
can be considered an optimal mode for BAPN administration. However, two considerations are important for the
use of this mode: the solubility of the compound and the
size of the pump. A commonly used infusion rate of
BAPN has been 150 mg/kg/d for osmotic pump delivery.
This dose requires a highly concentrated BAPN solution
(>500 mg/mL) to enable the use of osmotic pumps
(pump rate, w0.25 mL/h; model 2004; ALZET Osmotic
Pumps; Durect Corp, Cupertino, Calif). Since the maximal
solubility of BAPN in water is w50 mg/mL, it is challenging
to dissolve BAPN (150 mg/kg/d) completely. In addition,
the most commonly used osmotic pump, ALZET model
2004, is not recommended for use with mice
weighing <20 g, which is incompatible with its use in
young mice. Therefore, it is often not feasible to deliver
BAPN via an osmotic pump, especially to young mice
with a low body weight. Many recent studies have administered BAPN in the drinking water, with AngII delivered
through mini-osmotic pumps.42,43 This method appears
to be an optimal mode for the administration of BAPN
to young mice.
Multiple studies in which BAPN was administered in
drinking water have reported that the dose was
1 g/kg/d (Table I). However, it is unclear how this dose
was calculated. This dosage might be appropriate for a
mouse weighing w25 g that drink w 5 mL of water
daily.44 However, body weight and water consumption
may vary. In addition, mice aged 3 to 4 weeks will weigh
10 to 15 g, and their water consumption can be <5 mL/d.
Consequently, an estimated dose of 1 g/kg/d of BAPN is
likely to be inaccurate. Therefore, it would be preferable
to provide a more direct description of the BAPN dose,
such as 1 to 3 mg/mL42,45,46 or 0.2% to 0.6% [% wt/vol
(2-6 mg/mL)] as reported in selected studies.24,25,43,47-49
Although the common routes of BAPN administration
have been subcutaneous infusion using an osmotic
pump or drinking water, other routes have also been
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Table I. Administration of BAPN to study AAD in mice
BAPN administration

Mouse strain

Sex

Age,
weeks

Route

Dose

Duration, weeks

C57BL/10

Male

3

Drinking water

0.5 g/kg/d

C57BL/6a

Male

3

Drinking water

1 g/kg/d

2-4

4

C57BL/6J

Male

3

Drinking water

1 g/kg/d

1, 2, or 4

50
12,51-57
58-64

FVB

Male

3

Drinking water

1 g/kg/d

Mixed (C57BL/6a and SJL)

Male

3-4

Drinking water

0.3% wt/vol

8-30

45,46

C57BL/6J

Male

3-4

Drinking water

0.5% wt/vol

12

47,48

C57BL/6a

Male

3

Drinking water

0.6% wt/vol

4

49

a

Male

3

Diet

0.4%, 1%, or 1.5%

4

12

C57BL/6

4

References

12

AAD, Aortic aneurysm and dissection; BAPN, b-aminopropionitrile.
a
Substrain of C57BL/6 unknown.

reported, including administration via the diet,12,37 gastric
tube,26 or intraperitoneal injection.38 Adding BAPN to the
mouse diet had effects similar to that of administering
the compound via the drinking water. In the study by
Ren et al,12 mice were fed BAPN at doses of 0.4, 1, or
1.5 g/100 g in their food. All the mice fed 0.4 g/100 g
BAPN developed AAD (ﬁve died of aortic rupture). In
the mice fed 1 g/100 g BAPN, two of six mice had developed thoracic aortic dissection. However, aortic dissection was not observed in the mice fed the highest
dose. All BAPN-administered mice had lost body weight
in a dose-dependent manner. Although the basis for this
body weight loss was not determined, effects of BAPN on
the lipid and glucose metabolisms might have contributed to its mechanism.65,66 Because mixing BAPN in
the food is logistically more difﬁcult than dissolving the
compound in the drinking water, the latter is an easier
approach. Compared with food consumption ad libitum,
gastric tube administration and intraperitoneal injection
will provide more accurate and consistent administration of BAPN. However, the insertion of a gastric tube is
technically demanding and time-consuming. It can
also stress the mice, augmenting the formation of AAD
and adding a confounding factor. Only one study administered BAPN by intraperitoneal injection, which had
focused on aortic stiffness.38 Thus, the effect of intraperitoneal injection of BAPN on AAD formation has not yet
been studied.
Overall, the administration of BAPN (0.5% wt/vol) in the
drinking water will induce a high incidence of AAD in
young mice (age, 3-4 weeks). Because of the high incidence of AAD formation, this mouse model has facilitated investigations of whether an experimental
intervention will attenuate AAD. Since different doses
of BAPN can lead to differing severity of AAD, it is important to optimize the BAPN dose before performing
experiments.
Mouse strains and sex. The most frequently studied
mouse strain has been C57BL/6, with many studies

reporting the use of the C57BL/6J substrain. It is important to distinguish between the C57BL/6 substrains. The
C57BL/6J and C57BL/6N substrains have well-deﬁned
differences, including the recently demonstrated diversity in the development of aortopathies.67,68 It is also
important to consider different mouse strains when
designing an experiment because the strains have
different susceptibilities to BAPN-induced AAD. Male
FVB mice had a lower incidence of AAD compared with
age-matched male C57BL/6 mice (substrain not reported): a 25% incidence of AAD and no aortic rupture in
FVB mice vs an 87% incidence of AAD and a 37% incidence of aortic rupture in C57BL/6 mice.12 The high
incidence of AAD in C57BL/6 mice has illustrated that the
BAPN-induced AAD mouse model does not need a hypercholesterolemic background. However, no studies
have determined whether hypercholesterolemia will
augment the development of BAPN-induced AAD.
Sexual dimorphism has also been reported in AAD formation in humans and mice.69-77 In humans, AAD has
been more prevalent in men than in women,69 and the
outcomes have frequently been worse for women.70,71
Women have been shown to be more likely to experience mortality from aortic dissection, lower long-term
survival after surgery, and a greater frequency of cardiac
complications such as cardiac tamponade.70-73 In several
mouse models, the incidence and severity of abdominal
aortic aneurysms are sexually dimorphic, with greater
severity in male mice.74-77 Consistent with this premise,
a few studies have reported a lower incidence of AAD
in female mice coadministered BAPN and AngII.43,78
However, no studies have reported on sexual dimorphism when BAPN was administered alone.

PATHOLOGIC FEATURES OF BAPN-INDUCED AAD
Progression of BAPN-induced AAD
Most studies reported AAD formation within 4 weeks of
BAPN administration (Table I). No apparent pathologies
were noted within 7 days of BAPN administration. However, impairment of the endothelial layer was detected

JVSeVascular Science

Sawada et al

67

Volume 3, Number C

as early as 7 days after BAPN administration, which was
demonstrated with an Evans blue injection into the
angular vein 20 minutes before termination.58 After
7 days of BAPN administration, 00CD45þ cells were
detected, mainly in the tunica adventitia, and had
increased after 14 days. Neutrophils (Ly6Gþ cells) were
also detected in the adventitia after 7 days but were
not apparent after 14 days of BAPN administration.59 In
addition to the pronounced accumulation of red blood
cells, disruption of the elastic ﬁbers was observed after
2 weeks of BAPN administration. Severe fragmentation
of the elastic ﬁbers and medial dissection became
apparent after 3 weeks of BAPN administration. After
28 days of BAPN administration, the accumulation of
leukocytes at the site of medial rupture and the surrounding adventitia was evident.51-55,59-62,79 For mice surviving 4 weeks of BAPN administration, thrombi had
resolved; however, continuous leukocyte inﬁltration and
disorganized collagen deposition were still prominent.
After
prolonged
administration
of
BAPN
for
#12 weeks,47,48 pronounced thinning of the aortic wall
in the ascending and descending thoracic aortic regions
was observed. The prolonged administration of BAPN
can cause kyphosis and osteolathyrism in mice.80
No studies have reported detailed histologic features after protracted intervals of administration.
Tearing of the aortic wall leads to bleeding. If bleeding
is constrained by the media or adventitia, thrombi will
form, surrounding the ruptured media or adventitia.
Aortic rupture occurs if transmural bleeding ensues or
the thrombi fail to constrain the blood within the medial
and adventitial layers. In BAPN-administered mice, intraor transmedial dissection was observed, in addition to
luminal dilatation, predominantly in the thoracic aorta.12
The presence of medial dissection and the location of
aortic dilatations are distinct pathologic features of this
model compared with the AngII-induced abdominal
aortic aneurysm model, which demonstrates luminal
dilatation with adventitial dissection in the suprarenal
abdominal aorta.40 BAPN-induced AAD has high death
rate from aortic rupture. For mice that died of aortic
rupture, death has been noted as early as 10 days after
the initiation of BAPN and became more frequent after
14 days of BAPN administration. The rate of death from
aortic rupture has been reported to be ~ 50% to
80%.12,52-61,63,64,79
Although several studies have shown BAPN-induced
aortic pathologies at different time points, the systematic
determination of the sequential events during BAPN
administration from the initiation to the progression of
AAD is lacking. The data from previous studies, which
usually provided pathology information after a single
time point for 3- to 4-week-old mice administered
BAPN, have shown that the aortic rupture rate is high.
Also, recently formed or resolving hemorrhage in the
medial layers has been noted frequently, accompanied

by inﬂammatory cell accumulation, luminal dilation,
and profound elastin breaks and extracellular matrix
degradation.
Overall, the BAPN-induced AAD mimics several aspects
of the heterogeneity of human AAD (Table II). It might be
an optimal model to allow us to understand the molecular mechanisms and explore potential therapeutic strategies for AAD. To perform a detailed characterization of
the pathologic features over time throughout the
diseased regions, it would be helpful to extend the
observation period beyond 4 weeks, in addition to the
short intervals.
AAD location
Aortic dissection in humans can be categorized into
two types: Stanford types A and B. Stanford type A involves the ascending aorta with pathology in the
ascending aorta alone or extending to the descending
aorta, and type B includes pathologies initiated from
the descending aorta. The use of this classiﬁcation can
help to decide the therapeutic strategy. A type A dissection requires urgent surgical repair. In contrast, treatment of type B dissections has not been consistent.2,3
Therefore, it is important to elucidate the regionspeciﬁc mechanisms of AAD.
For BAPN-induced AAD, most studies have either
focused on thoracic AAD or did not specify the AAD location. One study reported that, in male C57BL/6 mice in
which BAPN administration had started at 3 weeks of
age, 87% had developed thoracic aortic dissection and
13% had developed abdominal aortic dissection.12 However, it was unclear whether the mice with abdominal
aortic dissection had also developed thoracic aortic
dissection. Thus, it is important to describe the region
of aortic dissection because concomitant thoracic and
abdominal aortic dissection would suggest that the initiation of aortic dissection had started from the thoracic
aortic region. In addition, the studies that had reported
thoracic aortic dissection, most had not speciﬁed
whether the aortic dissection had started in the
ascending aortic region, aortic arch, or descending
thoracic aortic region. The usefulness of this model
would be enhanced by investigators including regionspeciﬁc data, such as the aortic region of AAD initiation,
the extension of the involved aortic regions, and the
rupture location.
Molecular mechanisms of BAPN-induced AAD
Inﬂammation.
BAPN
administration
provoked
increased plasma concentrations of multiple inﬂammatory molecules, such as interleukin (IL)-1b, IL-2, IL-3, IL-6,
CD40 ligand, and tumor necrosis factor-a.50,56 A direct
link of these increases to the development of aortopathies has been demonstrated by whole body deletion
of either IL-3 or CD40 ligand that attenuated
BAPN-induced AAD formation.50,56 Also, deletion of
complement C3a receptor inhibited the development of
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Table II. Comparison of AAD between humans and
BAPN-administered mice
Humans

BAPN-administered mice

Aneurysm

Abdominal >
thoracic aorta

Thoracic >
abdominal aorta

Dissection

Thoracic aorta

Thoracic aorta

Media

Media

Elastin fragmentation

Yes

Yes

Collagen deposition

Yes

Yes

Inﬂammatory cell
accumulation

Yes

Yes

Feature
Location

False lumen
formation

AAD, Aortic aneurysm and dissection; BAPN, b-aminopropionitrile.

BAPN-induced AAD.53 In addition, the anti-inﬂammatory
compound, dexamethasone, attenuated BAPN-induced
AAD, accompanied by diminished inﬂammation.62
These ﬁndings support the idea that inﬂammation
plays a critical role in the development of BAPN-induced
AAD (Fig 1).
Metalloproteinase. Several studies have demonstrated
changes in metalloproteinases (MMPs) in mouse aortas
during BAPN administration, in particular, the gelatinases, MMP2 and MMP9. Some studies have uniformly
demonstrated
increased
MMP2
protein
and
mRNA,12,50,53,61,64 and aortic MMP9 protein was shown
to increase in all52,53,60,62,64 but two studies12,50 (Fig 1). In
addition to the gelatinases, several studies have reported
an increase in aortic MMP3.50,57,45 A causal role in the
changes of MMP abundance can be inferred from the
single study in which suppression of MMP2 using short
hairpin RNA attenuated BAPN-induced AAD formation.53
Although multiple studies have shown the contribution
of MMPs to the pathophysiology of BAPN-induced AAD, it
remains unknown how BAPN alters aortic MMPs. In
addition, BAPN has been assumed to cause AAD through
the inhibition of elastin and collagen crosslinking. Overall,
the precise role of MMPs in BAPN-induced AAD formation remains to be clariﬁed.
Smooth muscle cells. The loss of smooth muscle cells
(SMCs) in BAPN-induced AAD has been attributed to
apoptosis (Fig 1).52,54,55,60-62 Consistent with the promotion of SMC apoptosis, AKT phosphorylation was downregulated in mice after BAPN administration.52,60,79
However, phosphorylation of ERK is controversial in the
BAPN-induced AAD mouse model.62,79 A direct role of
SMC apoptosis has been inferred by the effects of rapamycin that prevented BAPN-induced AAD formation. It
is of note that intermittent hypoxia alleviated
BAPN-induced AAD with inhibition of SMC apoptosis.52
The effects of SMCs was also demonstrated by SMCspeciﬁc sirtuin-1 overexpression, which decreased the

Fig 1. Molecular mechanisms studied in b-aminopropionitrile (BAPN)-induced aortic aneurysm and
dissection (AAD) mouse model. IL, Interleukin; MMP,
metalloproteinase; SMC, smooth muscle cell.

BAPN-induced AAD rupture rate.64 Sirtuin-1 was reported to have antioxidative effects in the aorta.81
Despite these studies, the mechanism by which BAPN
induces SMC phenotypic changes has not yet been
deﬁned.
During the past decade, many molecular mechanisms
by which BAPN causes AAD formation have been
explored. However, many studies had used aortas harvested after 4 weeks of BAPN administration, which
could have had overt pathology, such as aneurysms
and dissections. Thus, it is difﬁcult to discern whether
the observed changes were a cause or a consequence
of the aortic pathology. For greater insight, it is important
to determine which changes are present at early intervals of BAPN administration before the appearance of
overt pathology.

IMAGING TOOLS FOR DETECTING
BAPN-INDUCED AAD
High-frequency ultrasound. With the advent of highfrequency ultrasound instruments, noninvasive ultrasound has been commonly used to monitor aortic
dilation in mice.82 Multiple studies have used ultrasound to assess BAPN-induced AAD.52-54,56-58,60,61,47,48,79
Most studies had measured the luminal diameters in
the proximal thoracic aorta as a parameter of AAD
severity. Right and left parasternal approaches are the
standard ultrasound modes for mice. However, these
modes are not optimal for descending aortic imaging
owing to interference from the lungs and ribs. A recent
study reported a paraspinal dorsal approach for ultrasound imaging in the descending aortic region of mice
(Fig 2, A).48 This approach can visualize aortic dilatations
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Fig 2. Imaging tools for detecting b-aminopropionitrile (BAPN-induced aortic aneurysm and dissection (AAD) in
mice. Representative aortic images of ultrasound48 (A), micro-computed tomography (CT),46 ex vivo (authors’
unpublished data; C), and in situ47 (D) approaches. OCT, Tissue-Tek optimal cutting temperature (compound;
Sakura Finetek, Torrance, Calif). Scale bar ¼ 1 mm.

and false lumen formation through the descending
thoracic aorta of BAPN-administered mice (Fig 2, A).

interesting to monitor BAPN-induced AAD formation
sequentially using micro-CT in live animals.

Micro-computed tomography. Micro-computed tomography (CT) is a modality used for the acquisition
of high-resolution aortic images of mice. Unlike ultrasound, micro-CT has less dependency on user skill for
acquiring aortic images that can be used for quantitation of dimensions. In addition, micro-CT readily enables evaluation of the aortic size in three dimensions,
which might provide more detailed structural information. Several studies have used micro-CT to detect
BAPN-induced aneurysms at study termination (Fig 2,
B).61,46 Despite detailed information with high reliability,
the necessity of an intravenous injection of contrast
agent has impeded the use of serial micro-CT imaging
studies. Sequential micro-CT monitoring has not been
reported for BAPN-administered mice. Because BAPN
leads to heterogeneous aortic pathologies, it would be

Magnetic resonance imaging. The mouse aorta can also
be visualized using magnetic resonance imaging (MRI).83
MRI does not result in radiation exposure and might not
require contrast agents for basic imaging of mouse aortas.
One study using MRI showed overt dilatation of the
proximal thoracic aorta in BAPN-administered mice that
was consistent with the ultrasound and ex vivo ﬁndings.53
However, the spatial resolution of MRI is not sufﬁcient to
assess small structural alterations in mouse aortas. Its
expense is also a barrier to the use of MRI. Thus, at present,
MRI cannot be routinely applied for evaluating aortic
morphology in mice.
Ex vivo and in situ imaging. Ex vivo approaches have
been used most frequently to evaluate BAPN-induced
AAD in mice (Fig 2, C).12,47,48,52-61,63,64,79 BAPN induces
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heterogeneous aortic pathologies in the entire thoracic
aorta. Because ex vivo approaches can detect AAD
directly in any region, it has advantages for the evaluation
of aortic pathologies in BAPN-administered mice. However, owing to the absence of blood pressure, it is difﬁcult
to maintain the aortic dimensions after euthanasia,
especially when severe pathologies are present. Therefore, formalin or latex perfusion has been used frequently
to maintain aortic patency during ex vivo imaging.84-86 In
situ imaging has also been a common approach for
aortic evaluations in mice.47,48,87 This approach can
assess aortic morphology while the tissue resides in the
anatomic position. A recent study demonstrated the
reliability of aortic measurements using in situ images
with optimal cutting temperature compound infused
into BAPN-induced AAD.47 Optimal cutting temperature
compound injection expanded the aortic lumen, and the
aortic diameters were comparable to the ultrasound
measurements (Fig 2, D). It is worth noting that the aortic
diameters using ex vivo or in situ images are external, not
luminal, diameters. Because external diameters will not
correspond to luminal diameters in aortic dissections,
other modalities, including ultrasound and micro-CT,
could be considered to assess the luminal diameters in
addition to external diameters.
Several modalities and methods are available to evaluate aortic morphology in mice. Because each approach
has different advantages and shortcomings, the imaging
approaches should be chosen to optimize the endpoints
of each study. In addition, the heterogeneity of BAPNinduced aortic pathologies has resulted in challenges
to aortic imaging for the acquisition of authentic measurements. Therefore, for robust evaluations, we would
recommend the use of multiple modes to validate
BAPN-induced aortic pathologies in mice.

SUMMARY AND PERSPECTIVES
BAPN-induced AAD replicates a spectrum of the features of human AAD (Table II). Thus, this mouse model
provides opportunities to study the complex mechanisms of AAD from the early to advanced stages for
exploring potential therapies. Although much research
is required to translate animal ﬁndings into human
uses, advances in research tools, including state-ofthe-art imaging systems and well-controlled pharmacologic studies, will provide insights into deﬁning
therapies for AAD. Prospectively, collaborations between basic science investigators and physician scientists will enhance our knowledge of AAD mechanisms
and pathophysiology in humans and provide ultimate
insights into translating the ﬁndings from animal
studies into human uses.
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